Craft
Can-Fite BioPharma

Can-Fite BioPharma

Revenue

$853 K

FY, 2021

Market Capitalization

₪3 B

2023-01-30

Can-Fite BioPharma Summary

Company summary

Overview
Can-Fite BioPharma is a biopharmaceutical company with pharmaceutical discovery and clinical development capabilities. It has a pipeline of proprietary compounds that address autoimmune-inflammatory and liver diseases.
Type
Public
Status
Active
Founded
1994
HQ
Petah Tikva, IL | view all locations
Website
http://www.canfite.com
Cybersecurity rating
Sectors

Key people

  • Ilan Cohn, Chairman

    • Pnina Fishman, Chief Executive Officer, Director

      • Abraham Sartani, Director

        LocationsView all

        1 location detected

        • Petah Tikva, Center District HQ

          Israel

          Bareket St 10, Petah Tikva

        Can-Fite BioPharma Financials

        Summary financials

        Revenue (Q3, 2022)
        $204.0K
        Gross profit (Q3, 2022)
        $204.0K
        Net income (Q3, 2022)
        ($2.5M)
        Cash (Q3, 2022)
        $3.7M
        EBIT (Q3, 2022)
        ($2.6M)
        Enterprise value
        $3.0B

        Footer menu